Design, synthesis and molecular docking and ADME studies of novel hydrazone derivatives for AChE inhibitory, BBB permeability and antioxidant effects

References

• Acar Çevik, U., Celik, I., Işık, A., Ahmad, I., Patel, H., Özkay, Y., & Kaplancıklı, Z. A. (2022). Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2022.2025906
   PubMed Web of Science ®Google Scholar
• Acar Cevik, U., Saglik, B. N., Levent, S., Osmaniye, D., Kaya Cavuşoglu, B., Ozkay, Y., & Kaplancikli, Z. A. (2019). Synthesis and AChE-inhibitory activity of new benzimidazole derivatives. Molecules, 24(5), 861. https://doi.org/10.3390/molecules24050861
   PubMed Web of Science ®Google Scholar
• Akasofu, S., Kimura, M., Kosasa, T., Sawada, K., & Ogura, H. (2008). Study of neuroprotection of donepezil, a therapy for Alzheimer’s disease. Chemico-Biological Interactions, 175(1–3), 222–226. https://doi.org/10.1016/j.cbi.2008.04.045
   PubMed Web of Science ®Google Scholar
• Alipour, M., Khoobi, M., Foroumadi, A., Nadri, H., Moradi, A., Sakhteman, A., Ghandi, M., & Shafiee, A. (2012). Novel coumarin derivatives bearing N-benzyl pyridinium moiety: Potent and dual binding site acetylcholinesterase inhibitors. Bioorganic & Medicinal Chemistry, 20(24), 7214–7222. https://doi.org/10.1016/j.bmc.2012.08.052
   PubMed Web of Science ®Google Scholar
• Al-Rashid, Z. F., & Hsung, R. P. (2015). A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase. Bioorganic & Medicinal Chemistry Letters, 25(21), 4848–4853. https://doi.org/10.1016/j.bmcl.2015.06.047
   PubMed Web of Science ®Google Scholar
• Alzheimer's Association. (2019). 2019 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia, 15, 321–387.
   Web of Science ®Google Scholar
• Arslan, T., Çakır, N., Keleş, T., Biyiklioglu, Z., & Senturk, M. (2019). Triazole substituted metal-free, metallo-phthalocyanines and their water soluble derivatives as potential cholinesterases inhibitors: Design, synthesis and in vitro inhibition study. Bioorganic Chemistry, 90, 103100. https://doi.org/10.1016/j.bioorg.2019.103100
   PubMed Web of Science ®Google Scholar
• Arslan, T., Ceylan, M. B., Baş, H., Biyiklioglu, Z., & Senturk, M. (2020). Design, synthesis, characterization of peripherally tetra-pyridine-triazole-substituted phthalocyanines and their inhibitory effects on cholinesterases (AChE/BChE) and carbonic anhydrases (hCA I, II and IX). Dalton Transactions, 49(1), 203–209. https://doi.org/10.1039/c9dt03897c
   PubMed Web of Science ®Google Scholar
• Berman, H. A., Yguerabide, J., & Taylor, P. (1980). Fluorescence energy transfer on acetylcholinesterase: Spatial relationship between peripheral site and active center. Biochemistry, 19(10), 2226–2235. https://doi.org/10.1021/bi00551a036
   PubMed Web of Science ®Google Scholar
• Bharadwaj, K. K., Ahmad, I., Pati, S., Ghosh, A., Sarkar, T., Rabha, B., Patel, H., Baishya, D., Edinur, H. A., Abdul Kari, Z., Ahmad Mohd Zain, M. R., & Wan Rosli, W. I. (2022). Potent bioactive compounds from seaweed waste to combat cancer through bioinformatics investigation. Frontiers in Nutrition, 9, 889276. https://doi.org/10.3389/fnut.2022.889276
   PubMed Web of Science ®Google Scholar
• Boulaamane, Y., Ahmad, I., Patel, H., Das, N., Britel, M. R., & Maurady, A. (2022). Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2022.2033643
   PubMed Web of Science ®Google Scholar
• Budimir, A. (2011). Metal ions, Alzheimer’s disease and chelation therapy. Acta Pharmaceutica, 61(1), 1–14. https://doi.org/10.2478/v10007-011-0006-6
   PubMed Web of Science ®Google Scholar
• Cavdar, H., Senturk, M., Guney, M., Durdagi, S., Kayik, G., Supuran, C. T., & Ekinci, D. (2019). Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: Kinetic and computational studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 34(1), 429–437. https://doi.org/10.1080/14756366.2018.1543288
   PubMed Web of Science ®Google Scholar
• Cevik, U., Levent, S., Saglık, B., Ozkay, Y., & Kaplancıklı, Z. (2017). Synthesis of novel 4-(dimethylaminoalkyl) piperazine-1-carbodithioate derivatives as cholinesterase inhibitors. Letters in Drug Design & Discovery, 14(5), 528–539. https://doi.org/10.2174/1570180813666160923105636
   Web of Science ®Google Scholar
• Cheung, J., Rudolph, M. J., Burshteyn, F., Cassidy, M. S., Gary, E. N., Love, J., Franklin, M. C., & Height, J. J. (2012). Structures of human acetylcholinesterase in complex with pharmacologically important ligands. Journal of Medicinal Chemistry, 55(22), 10282–10286. https://doi.org/10.1021/jm300871x
   PubMed Web of Science ®Google Scholar
• Darvesh, S., Hopkins, D., & Geula, C. (2003). Neurobiology of butyrylcholinesterase. Nature Reviews Neuroscience, 4(2), 131–138. https://doi.org/10.1038/nrn1035
   PubMed Web of Science ®Google Scholar
• dos Santos, P., Leide, C., Ozela, P. F., de Fatima de Brito Brito, M., Pinheiro, A. A., Padilha, E. C., Braga, F. S., de Paula, d., Carlos, H., & dos Santos, C. B. R. (2018). Alzheimer’s disease: A review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment. Current Medicinal Chemistry, 25(26), 3141–3159. https://doi.org/10.2174/0929867323666161213101126
   PubMed Web of Science ®Google Scholar
• Du, X., Wang, X., & Geng, M. (2018). Alzheimer’s disease hypothesis and related therapies. Translational Neurodegeneration, 7, 2–7. https://doi.org/10.1186/s40035-018-0107-y
   PubMed Web of Science ®Google Scholar
• Ellman, G. L., Courtney, K. D., Andres, V., & Feather-Stone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7, 88–95. https://doi.org/10.1016/0006-2952(61)90145-9
   PubMed Web of Science ®Google Scholar
• Fernández-Bachiller, M. I., Pérez, C., González-Muñoz, G. C., Conde, S., López, M. G., Villarroya, M., García, A. G., & Rodríguez-Franco, M. I. (2010). Novel tacrine–8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. Journal of Medicinal Chemistry, 53(13), 4927–4937. https://doi.org/10.1021/jm100329q
   PubMed Web of Science ®Google Scholar
• Genest, D., Rochais, C., Lecoutey, C., Sopkova-de Oliveira Santos, J., Ballandonne, C., Butt-Gueulle, S., Legay, R., Since, M., & Dallemagne, P. (2013). Design, synthesis and biological evaluation of novel indano-and thiaindano-pyrazoles with potential interest for Alzheimer’s disease. MedChemComm, 4(6), 925–931. https://doi.org/10.1039/c3md00041a
   Web of Science ®Google Scholar
• Ghosh, S., Das, S., Ahmad, I., & Patel, H. (2021). In silico validation of anti-viral drugs obtained from marine sources as a potential target against SARS-CoV-2 Mpro. Journal of the Indian Chemical Society, 98(12), 100272. https://doi.org/10.1016/j.jics.2021.100272
   Web of Science ®Google Scholar
• Girase, R., Ahmad, I., Pawara, R., & Patel, H. (2022). Optimizing cardio, hepato and phospholipidosis toxicity of the Bedaquiline by chemoinformatics and molecular modelling approach. SAR and QSAR in Environmental Research, 33(3), 215–235. https://doi.org/10.1080/1062936X.2022.2041724
   PubMed Web of Science ®Google Scholar
• Holzgrabe, U., Kapková, P., Alptüzün, V., Scheiber, J., & Kugelmann, E. (2007). Targeting acetylcholinesterase to treat neurodegeneration. Expert Opinion on Therapeutic Targets, 11(2), 161–179. https://doi.org/10.1517/14728222.11.2.161
   PubMed Web of Science ®Google Scholar
• Hussein, W., Sağlık, B. N., Levent, S., Korkut, B., Ilgın, S., Özkay, Y., & Kaplancıklı, Z. A. (2018). Synthesis and biological evaluation of new cholinesterase inhibitors for Alzheimer’s disease. Molecules, 23(8), 2033. https://doi.org/10.3390/molecules23082033
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236. https://doi.org/10.1021/ja9621760
   Web of Science ®Google Scholar
• Kalibaeva, G., Ferrario, M., & Ciccotti, G. (2003). Constant pressure-constant temperature molecular dynamics: A correct constrained NPT ensemble using the molecular virial. Molecular Physics, 101(6), 765–778. https://doi.org/10.1080/0026897021000044025
   Web of Science ®Google Scholar
• LaFerla, F. M., Green, K. N., & Oddo, S. (2007). Intracellular amyloid-β in Alzheimer’s disease. Nature Reviews Neuroscience, 8(7), 499–509. https://doi.org/10.1038/nrn2168
   PubMed Web of Science ®Google Scholar
• Lee, H. Y., Cho, D. Y., Ahmad, I., Patel, H. M., Kim, M. J., Jung, J. G., Jeong, E. H., Haque, M. A., & Cho, K. M. (2021). Mining of a novel esterase (est3S) gene from a cow rumen metagenomic library with organosphosphorus insecticides degrading capability: Catalytic insights by site directed mutations, docking, and molecular dynamic simulations. International Journal of Biological Macromolecules, 190, 441–455. https://doi.org/10.1016/j.ijbiomac.2021.08.224
   PubMed Web of Science ®Google Scholar
• Levent, S., Acar Çevik, U., Sağlık, B. N., Özkay, Y., Can, Ö. D., Özkay, Ü. D., & Uçucu, Ü. (2017). Anticholinesterase activity screening of some novel dithiocarbamate derivatives including piperidine and piperazine moieties. Phosphorus, Sulfur, and Silicon and the Related Elements, 192(4), 469–474. https://doi.org/10.1080/10426507.2016.1259228
   Web of Science ®Google Scholar
• Makhaeva, G. F., Lushchekina, S. V., Kovaleva, N. V., Yu Astakhova, T., Boltneva, N. P., Rudakova, E. V., Serebryakova, O. G., Proshin, A. N., Serkov, I. V., Trofimova, T. P., Tafeenko, V. A., Radchenko, E. V., Palyulin, V. A., Fisenko, V. P., Korábečný, J., Soukup, O., & Richardson, R. J. (2021). Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer’s disease treatment. Bioorganic Chemistry, 112, 104974. https://doi.org/10.1016/j.bioorg.2021.104974
   PubMed Web of Science ®Google Scholar
• Martyna, G. J. (1994). Remarks on “Constant-temperature molecular dynamics with momentum conservation”. Physical Review E: Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics, 50(4), 3234–3236. https://doi.org/10.1103/physreve.50.3234
   PubMed Web of Science ®Google Scholar
• Mayeux, R. (2003). Epidemiology of neurodegeneration. Annual Review of Neuroscience, 26, 81–104. https://doi.org/10.1146/annurev.neuro.26.043002.094919
   PubMed Web of Science ®Google Scholar
• Meena, P., Nemaysh, V., Khatri, M., Manral, A., Luthra, P. M., & Tiwari, M. (2015). Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer’s disease. Bioorganic & Medicinal Chemistry, 23(5), 1135–1148. https://doi.org/10.1016/j.bmc.2014.12.057
   PubMed Web of Science ®Google Scholar
• Neochoritis, C., Tsoleridis, C. A., & Stephanidou-Stephanatou, J. (2008). 1-Arylaminoimidazole-2-thiones as intermediates in the synthesis of imidazo [2,1-b][1,3,4] thiadiazines. Tetrahedron, 64(16), 3527–3533. https://doi.org/10.1016/j.tet.2008.01.136
   Web of Science ®Google Scholar
• Onder, F. C., Sahin, K., Senturk, M., Durdagi, S., & Ay, M. (2022). Identifying highly effective coumarin-based novel cholinesterase inhibitors by in silico and in vitro studies. Journal of Molecular Graphics & Modelling, 115, 108210. https://doi.org/10.1016/j.jmgm.2022.108210
   PubMed Web of Science ®Google Scholar
• Osmaniye, D., Sağlık, B. N., Acar Çevik, U., Levent, S., Kaya Çavuşoğlu, B., Özkay, Y., Kaplancıklı, Z. A., & Turan, G. (2019). Synthesis and AChE inhibitory activity of novel thiazolylhydrazone derivatives. Molecules, 24(13), 2392. https://doi.org/10.3390/molecules24132392
   PubMed Web of Science ®Google Scholar
• Özil, M., Balaydın, H. T., & Şentürk, M. (2019). Synthesis of 5-methyl-2,4-dihydro-3H-1,2,4-triazole-3-one’s aryl Schiff base derivatives and investigation of carbonic anhydrase and cholinesterase (AChE, BuChE) inhibitory properties. Bioorganic Chemistry, 86, 705–713. https://doi.org/10.1016/j.bioorg.2019.02.045
   PubMed Web of Science ®Google Scholar
• Özkay, Ü. D., Can, Ö. D., Sağlık, B. N., Çevik, U. A., Levent, S., Özkay, Y., Ilgın, S., & Atlı, Ö. (2016). Design, synthesis, and AChE inhibitory activity of new benzothiazole–piperazines. Bioorganic & Medicinal Chemistry Letters, 26(22), 5387–5394. https://doi.org/10.1016/j.bmcl.2016.10.041
   PubMed Web of Science ®Google Scholar
• Pawara, R., Ahmad, I., Nayak, D., Belamkar, S., Surana, S., Kundu, C. N., Patil, C., & Patel, H. (2022). Design and synthesis of the novel, selective WZ4002 analogue as EGFR-L858R/T790M tyrosine kinase inhibitors for targeted drug therapy in non-small-cell lung cancer (NSCLC). Journal of Molecular Structure, 1254, 132313. https://doi.org/10.1016/j.molstruc.2021.132313
   Web of Science ®Google Scholar
• Pawara, R., Ahmad, I., Nayak, D., Wagh, S., Wadkar, A., Ansari, A., Belamkar, S., Surana, S., Nath Kundu, C., Patil, C., & Patel, H. (2021). Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M non-small-cell lung cancer (NSCLC). Bioorganic Chemistry, 115, 105234. https://doi.org/10.1016/j.bioorg.2021.105234
   PubMed Web of Science ®Google Scholar
• Pawara, R., Ahmad, I., Surana, S., & Patel, H. (2021). Computational identification of 2,4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulation. In Silico Pharmacology, 9(1), 22. https://doi.org/10.1007/s40203-021-00113-x
   PubMedGoogle Scholar
• Pievani, M., de Haan, W., Wu, T., Seeley, W. W., & Frisoni, G. B. (2011). Functional network disruption in the degenerative dementias. The Lancet Neurology, 10(9), 829–843. https://doi.org/10.1016/S1474-4422(11)70158-2
   PubMed Web of Science ®Google Scholar
• Rennekamp, A. J., Huang, X.-P., Wang, Y., Patel, S., Lorello, P. J., Cade, L., Gonzales, A. P. W., Yeh, J.-R J., Caldarone, B. J., Roth, B. L., Kokel, D., & Peterson, R. T. (2016). σ1 receptor ligands control a switch between passive and active threat responses. Nature Chemical Biology, 12(7), 552–558. https://doi.org/10.1038/nchembio.2089
   PubMed Web of Science ®Google Scholar
• Sağlık, B. N., Ilgın, S., & Özkay, Y. (2016). Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes. European Journal of Medicinal Chemistry, 124, 1026–1040. https://doi.org/10.1016/j.ejmech.2016.10.042
   PubMed Web of Science ®Google Scholar
• Sağlık, B. N., Osmaniye, D., Acar Çevik, U., Levent, S., Kaya Çavuşoğlu, B., Özkay, Y., & Kaplancıklı, Z. A. (2020). Design, synthesis, and structure–activity relationships of thiazole analogs as anticholinesterase agents for Alzheimer’s disease. Molecules, 25(18), 4312. https://doi.org/10.3390/molecules25184312
   PubMed Web of Science ®Google Scholar
• Schrödinger, LLC. (2014). Schrödinger Release, 1: Desmond molecular dynamics system, version 3.7, DE Shaw Research, New York, NY, Maestro-Desmond Interoperability Tools, version, 3. Schrödinger, LLC.
   Google Scholar
• Schrödinger, LLC. (2016a). Maestro (Version 10.6). Schrödinger, LLC.
   Google Scholar
• Schrödinger, LLC. (2016b). Schrödinger Suite 2020 Update 2. Schrödinger, LLC.
   Google Scholar
• Schrödinger, LLC. (2016c). LigPrep (Version 3.8). Schrödinger, LLC.
   Google Scholar
• Schrödinger, LLC. (2016d). Glide (Version 7.1). Schrödinger, LLC.
   Google Scholar
• Shaik, J. B., Palaka, B. K., Penumala, M., Kotapati, K. V., Devineni, S. R., Eadlapalli, S., Darla, M. M., Ampasala, D. R., Vadde, R., & Amooru, G. D. (2016). Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. European Journal of Medicinal Chemistry, 107, 219–232. https://doi.org/10.1016/j.ejmech.2015.10.046
   PubMed Web of Science ®Google Scholar
• Silva, D., Chioua, M., Samadi, A., Agostinho, P., Garção, P., Lajarín-Cuesta, R., de Los Ríos, C., Iriepa, I., Moraleda, I., Gonzalez-Lafuente, L., Mendes, E., Pérez, C., Rodríguez-Franco, M. I., Marco-Contelles, J., & Carmo Carreiras, M. (2013). Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: Effect against amyloid-β-induced neurotoxicity. ACS Chemical Neuroscience, 4(4), 547–565. https://doi.org/10.1021/cn300178k
   PubMed Web of Science ®Google Scholar
• Skovronsky, D. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2006). Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications. Annual Review of Pathology, 1, 151–170. https://doi.org/10.1146/annurev.pathol.1.110304.100113
   PubMed Web of Science ®Google Scholar
• Tok, F., Koçyiğit-Kaymakçıoğlu, B., Sağlık, B. N., Levent, S., Özkay, Y., & Kaplancıklı, Z. A. (2019). Synthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors. Bioorganic Chemistry, 84, 41–50. https://doi.org/10.1016/j.bioorg.2018.11.016
   PubMed Web of Science ®Google Scholar
• Vickers, N. J. (2017). Animal communication: When I’m calling you, will you answer too? Current Biology, 27(14), R713–R715. https://doi.org/10.1016/j.cub.2017.05.064
   PubMed Web of Science ®Google Scholar
• Yan, G., Hao, L., Niu, Y., Huang, W., Wang, W., Xu, F., Liang, L., Wang, C., Jin, H., & Xu, P. (2017). 2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl) acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies. European Journal of Medicinal Chemistry, 137, 462–475. https://doi.org/10.1016/j.ejmech.2017.06.020
   PubMed Web of Science ®Google Scholar
• Youssef, K. M., Fawzy, I. M., & El-Subbagh, H. I. (2018). N-substituted-piperidines as novel anti-Alzheimer agents: Synthesis, antioxidant activity, and molecular docking study. Future Journal of Pharmaceutical Sciences, 4(1), 1–7. https://doi.org/10.1016/j.fjps.2017.06.002
   Web of Science ®Google Scholar